Genome-wide polygenic scores for common diseases identify individuals with risk equivalent to monogenic mutations
Top Cited Papers
- 13 August 2018
- journal article
- research article
- Published by Springer Science and Business Media LLC in Nature Genetics
- Vol. 50 (9), 1219-1224
- https://doi.org/10.1038/s41588-018-0183-z
Abstract
A key public health need is to identify individuals at high risk for a given disease to enable enhanced screening or preventive therapies. Because most common diseases have a genetic component, one important approach is to stratify individuals based on inherited DNA variation1. Proposed clinical applications have largely focused on finding carriers of rare monogenic mutations at several-fold increased risk. Although most disease risk is polygenic in nature2,3,4,5, it has not yet been possible to use polygenic predictors to identify individuals at risk comparable to monogenic mutations. Here, we develop and validate genome-wide polygenic scores for five common diseases. The approach identifies 8.0, 6.1, 3.5, 3.2, and 1.5% of the population at greater than threefold increased risk for coronary artery disease, atrial fibrillation, type 2 diabetes, inflammatory bowel disease, and breast cancer, respectively. For coronary artery disease, this prevalence is 20-fold higher than the carrier frequency of rare monogenic mutations conferring comparable risk6. We propose that it is time to contemplate the inclusion of polygenic risk prediction in clinical care, and discuss relevant issues.Keywords
This publication has 38 references indexed in Scilit:
- CorrectionJournal of the American College of Cardiology, 2014
- Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: Consensus Statement of the European Atherosclerosis SocietyEuropean Heart Journal, 2013
- Projecting the performance of risk prediction based on polygenic analyses of genome-wide association studiesNature Genetics, 2013
- Rare and common variants: twenty argumentsNature Reviews Genetics, 2012
- Charting a course for genomic medicine from base pairs to bedsideNature, 2011
- A multilocus genetic risk score for coronary heart disease: case-control and prospective cohort analysesThe Lancet, 2010
- Inflammatory Bowel DiseaseThe New England Journal of Medicine, 2009
- Polygenes, Risk Prediction, and Targeted Prevention of Breast CancerThe New England Journal of Medicine, 2008
- Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or MetforminThe New England Journal of Medicine, 2002
- XV.—The Correlation between Relatives on the Supposition of Mendelian Inheritance.Transactions of the Royal Society of Edinburgh, 1919